Brincidofovir for prevention of cytomegalovirus (CMV) after allogeneic hematopoietic cell transplantation (HCT) in CMV-seropositive patients: A pandomized, double-blind, placebo-controlled, parallel-group phase 3 trial Meeting Abstract
| Authors: | Marty, F. M.; Winston, D. J.; Chemaly, R. F.; Boeckh, M. J.; Mullane, K. M.; Shore, T. B.; Papanicolaou, G. A.; Morrison, M. E.; Brundage, T. M.; Mommeja-Marin, H. |
| Abstract Title: | Brincidofovir for prevention of cytomegalovirus (CMV) after allogeneic hematopoietic cell transplantation (HCT) in CMV-seropositive patients: A pandomized, double-blind, placebo-controlled, parallel-group phase 3 trial |
| Meeting Title: | 2016 BMT Tandem Meetings |
| Journal Title: | Biology of Blood and Marrow Transplantation |
| Volume: | 22 |
| Issue: | 3 Suppl. 1 |
| Meeting Dates: | 2016 Feb 18-22 |
| Meeting Location: | Honolulu, HI |
| ISSN: | 1083-8791 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2016-03-01 |
| Start Page: | S23 |
| Language: | English |
| ACCESSION: | WOS:000370910300010 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.bbmt.2016.01.009 |
| Notes: | Meeting Abstract: 5 -- Source: Wos |
